Overview

A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This multi-center, two-treatment study compares the pharmacokinetic profiles of Immediate Release (IR) and Modified Release (MR) formulations of Topiramate (TPM) in patients with epilepsy.
Phase:
Phase 1
Details
Lead Sponsor:
Supernus Pharmaceuticals, Inc.
Treatments:
Topiramate